Neith Corporation

TWO:6236 Taiwan Biotechnology
Market Cap
$27.19 Million
NT$899.73 Million TWD
Market Cap Rank
#32744 Global
#1886 in Taiwan
Share Price
NT$21.60
Change (1 day)
+0.00%
52-Week Range
NT$19.60 - NT$31.50
All Time High
NT$31.50
About

Neith Corporation engages in the biotechnology, medical cosmetics, and preventive medicine businesses. The company offers nutritional products, including L-One, a liquid formula for maintaining eye health; EPlus, a multiple enzyme supplement; and other nutritional products under the King One name. It also provides genetic testing services. In addition, the company offers energy and dual-purpose m… Read more

Neith Corporation (6236) - Total Assets

Latest total assets as of September 2025: NT$168.17 Million TWD

Based on the latest financial reports, Neith Corporation (6236) holds total assets worth NT$168.17 Million TWD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Neith Corporation - Total Assets Trend (2021–2024)

This chart illustrates how Neith Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Neith Corporation - Asset Composition Analysis

Current Asset Composition (December 2024)

Neith Corporation's total assets of NT$168.17 Million consist of 83.6% current assets and 16.4% non-current assets.

Asset Category Amount (TWD) % of Total Assets
Cash & Equivalents NT$0.00 77.9%
Accounts Receivable NT$7.08 Million 4.2%
Inventory NT$315.00K 0.2%
Property, Plant & Equipment NT$0.00 0.0%
Intangible Assets NT$0.00 0.0%
Goodwill NT$0.00 0.0%

Asset Composition Trend (2021–2024)

This chart illustrates how Neith Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Neith Corporation's current assets represent 83.6% of total assets in 2024, an increase from 68.6% in 2021.
  • Cash Position: Cash and equivalents constituted 77.9% of total assets in 2024, up from 47.0% in 2021.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
  • Asset Diversification: The largest asset category is accounts receivable at 4.2% of total assets.

Neith Corporation Competitors by Total Assets

Key competitors of Neith Corporation based on total assets are shown below.

Company Country Total Assets
MedPacto Inc
KQ:235980
Korea ₩51.58 Billion
2H0
F:2H0
Germany €15.27 Million
Shenzhen CAU Technology Co Ltd
SHE:000004
China CN¥260.55 Million
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
China CN¥9.58 Billion
Nanhua Bio Medicine Co Ltd
SHE:000504
China CN¥841.96 Million
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
China CN¥509.14 Million
Chengzhi Shareholding Co Ltd
SHE:000990
China CN¥27.52 Billion
Hualan Biological EngineeringInc
SHE:002007
China CN¥16.27 Billion

Neith Corporation - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.14 - 0.41

Lower asset utilization - Neith Corporation generates 0.27x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -20.83% - -6.97%

Negative ROA - Neith Corporation is currently not profitable relative to its asset base.

Neith Corporation - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 17.06 19.11 19.11
Quick Ratio 17.06 19.05 19.05
Cash Ratio 0.00 0.00 0.00
Working Capital NT$137.41 Million NT$ 133.70 Million NT$ 133.70 Million

Neith Corporation - Advanced Valuation Insights

This section examines the relationship between Neith Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.81
Latest Market Cap to Assets Ratio 0.02
Asset Growth Rate (YoY) -11.1%
Total Assets NT$170.88 Million
Market Capitalization $3.26 Million USD

Valuation Analysis

Below Book Valuation: The market values Neith Corporation's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Neith Corporation's assets decreased by 11.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Neith Corporation (2021–2024)

The table below shows the annual total assets of Neith Corporation from 2021 to 2024.

Year Total Assets Change
2024-12-31 NT$170.88 Million -11.07%
2023-12-31 NT$192.15 Million -16.04%
2022-12-31 NT$228.86 Million +198.17%
2021-12-31 NT$76.75 Million --